Skip to main content

Thyroid Gland Carcinoma clinical trials at UCSF

1 research study open to eligible people

Showing trials for
  • Gallium-68 Prostate Specific Membrane Antigen PET in Diagnosing Patients With Thyroid Cancer

    open to eligible people ages 18 years and up

    This pilot clinical trial studies how well Gallium-68 prostate specific membrane antigen positron emission tomography (PET) work in diagnosing patients with thyroid cancer. Diagnostic procedures, such as 68Ga-PSMA PET, may more accurately diagnose thyroid cancer and find out how far the disease has spread.

    San Francisco, California

Last updated: